DocGo reports Q3 EPS (28c) vs 5c last year

Reports Q3 rvenue $70.8M, consensus $69.16M. Lee Bienstock, Chief Executive Officer of DocGo (DCGO), commented, “I’m proud of what we have accomplished during this year of transition, with our core mobile health and medical transportation businesses all achieving record volumes in the third quarter. I want to emphasize that each of our service lines, with the exception of our care gap closure and primary care offerings, is adjusted EBITDA positive on a contribution basis. We continue to believe that the substantial investment we made this year into our care gap and primary care offerings, which bring the capabilities of a doctor’s office into the patient’s living room, offers significant strategic value, and we are seeing notable expansions with our major payer customers to support that view. We expect our level of investment to decline significantly in 2026 as our early markets mature and become more self-sustaining.”